Form 8-K - Current report:
SEC Accession No. 0001104659-25-016181
Filing Date
2025-02-21
Accepted
2025-02-21 17:15:19
Documents
18
Period of Report
2025-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm257154d1_8k.htm   iXBRL 8-K 35088
2 EXHIBIT 4.1 tm257154d1_ex4-1.htm EX-4.1 102689
3 EXHIBIT 4.2 tm257154d1_ex4-2.htm EX-4.2 143347
4 EXHIBIT 4.3 tm257154d1_ex4-3.htm EX-4.3 126703
5 EXHIBIT 10.1 tm257154d1_ex10-1.htm EX-10.1 216425
6 EXHIBIT 99.1 tm257154d1_ex99-1.htm EX-99.1 11605
  Complete submission text file 0001104659-25-016181.txt   968044

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20250217.xsd EX-101.SCH 3027
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20250217_lab.xml EX-101.LAB 34240
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20250217_pre.xml EX-101.PRE 22367
20 EXTRACTED XBRL INSTANCE DOCUMENT tm257154d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 25653156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)